Vimarsana
Biggest News Aggregation in the World

Page 17 - Adaptive Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adaptive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adaptive Research Today - Breaking & Trending Today

NA Proactive news snapshot: PyroGenesis Canada Inc, RedHill Biopharma Ltd, Australis Capital Inc, Energy Fuels Inc, Marvel Discovery Corp, Safe-T Group Ltd, Altiplano Metals Inc, Esports Entertainment Group Inc, FPX Nickel Corp UPDATE … - Vimarsana News

NA Proactive news snapshot: PyroGenesis Canada Inc, RedHill Biopharma Ltd, Australis Capital Inc, Energy Fuels Inc, Marvel Discovery Corp, Safe-T Group Ltd, Altiplano Metals Inc, Esports Entertainment Group Inc, FPX Nickel Corp UPDATE …

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Kintara Therapeutics, Inc. says VAL-083 treatment arm in the Phase 2/3 clinical trial for glioblastoma multiforme has now been activated in 15 US sites - Vimarsana News

Kintara Therapeutics, Inc. says VAL-083 treatment arm in the Phase 2/3 clinical trial for glioblastoma multiforme has now been activated in 15 US sites

The trial, titled GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment), is a patient-centered, adaptive platform trial for...

(KTRA) - Kintara Stock Soars After Site Activation Update On Glioblastoma Trial - Vimarsana News

(KTRA) - Kintara Stock Soars After Site Activation Update On Glioblastoma Trial

Kintara Therapeutics Inc (NASDAQ: KTRA) has announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research registrational Phase ...

Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma - Vimarsana News

Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma

Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma News provided by Share this article Share this article SAN DIEGO, May 26, 2021 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research (GCAR) registrational Phase 2/3 clinical trial for glioblastoma multiforme (GBM) has been activated in 15 U.S. sites as of May 14, 20...

BioBuzz celebrates Asian/Pacific American Heritage (AAPI) Month · BioBuzz - Vimarsana News

BioBuzz celebrates Asian/Pacific American Heritage (AAPI) Month · BioBuzz

Asian/Pacific American Heritage (AAPI) Month is celebrated annually during the month of May. It marks the celebration of Asians and Pacific Islanders in the United States. It includes people having origins from the continent of Asia and the Pacific islands of Melanesia and Polynesia. Asian Americans and Pacific Islanders have a rich culture and heritage spanning thousands of years that have shaped the modern history of the US.  AAPI Heritage commemoration was first proposed in 1977 to observe the immigration of the first Japanese to the US (May 7, 1843) and the completion of the transcontine...

Source: biobuzz.io